About Op Pharma Distributor Private Limited
Data last updated: 09 February 2026
Op Pharma Distributor Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 28 November 2018, the company has been in operation for over 8 years.
Registered with ROC Kanpur under CIN U51909UP2018PTC110696.
Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.69 Lakh. It is led by directors including Raj Kumar and Poonam Hisaria.
Last AGM: 31 October 2023. Financial statements filed for year ended 31 March 2023. Office: 462 Sf Sk (Shakti Khand) Iii Indirapuram, Ghaziabad, Uttar Pradesh, India – 201010.
As per the financials filed for FY 2023, the company reported a revenue of ₹19.82 Cr, a decline of 35% compared to the previous year.
The company has a workforce of approximately 5 employees as per the latest available data.
The company is associated with 1 brand - Op Pharma Distributor. As per MCA filings, the company has open charges of ₹3.87 Cr on record.
For more details, the company can be reached via its website oppharma.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address462 Sf Sk (Shakti Khand) Iii Indirapuram, Ghaziabad, Uttar Pradesh, India – 201010
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Op Pharma Distributor Private Limited
Op Pharma Distributor Private Limited operates one associated brand: Op Pharma Distributor. These brands represent Op Pharma Distributor Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| A pharmaceutical distributor offering cooperative programs for student development. | oppharma.in |
Competitors & Alternatives of Op Pharma Distributor Private Limited
Brands and companies operating in the same space as Op Pharma Distributor Private Limited include Entero Healthcare, AmerisourceBergen, Keimed and 3 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Entero Healthcare
|
India's leading healthcare products distribution platform | Mumbai, India, India | 2018 |
AmerisourceBergen
|
Pharmaceutical distribution and supply chain services are provided globally. | Chesterbrook, United States, United States | 1985 |
Keimed
|
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | Hyderabad, India, India | 2000 |
Sandor Medicaids
|
Provider of medical equipment, devices, and drugs distribution services | Hyderabad, India, India | 1995 |
Dipna Pharmachem
|
Distributor of pharmaceutical raw materials | Ahmedabad, India, India | 2011 |
Mahaveer Medi Sales
|
Serves as a distributor of a wide range of pharmaceutical drugs. | Bengaluru, India, India | 2016 |
Business Activity of Op Pharma Distributor Private Limited
Op Pharma Distributor Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Op Pharma Distributor Private Limited
Op Pharma Distributor Private Limited is audited by ALOK HIRA & ASSOCIATES for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ALOK HIRA & ASSOCIATES | blur-value | blur-value | blur-value |
Board of Directors of Op Pharma Distributor Private Limited
Op Pharma Distributor Private Limited is currently managed by 4 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Raj Kumar
Also directs:
Healthaura Pharma Services Llp
|
Director | 02 Mar 2021 | 5 Years 4 Months | Current |
|
Poonam Hisaria
Also directs:
Healthaura Pharma Services Llp
|
Director | 20 May 2019 | 7 Years 1 Months | Current |
|
Yogvir Singh
Also directs:
Jaymapp International Private Limited, Jmd Consultants India Private Limited, Kma Pharma Private Limited and 2 more
|
Additional Director | 27 Mar 2024 | 2 Years 3 Months | Current |
|
Sunder Pal
Also directs:
Jaymapp International Private Limited, Kma Pharma Private Limited
|
Additional Director | 03 Sep 2024 | 1 Years 10 Months | Current |
Financials of Op Pharma Distributor Private Limited FY 2023 filings available
Op Pharma Distributor Private Limited reported revenue of ₹19.82 Cr (down 35% YoY) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Op Pharma Distributor Private Limited
As of FY 2021, Op Pharma Distributor Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Op Pharma Distributor Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2022 | Others | ₹70.89 Lakh | Open |
| 26 Jun 2020 | Others | ₹16.34 Lakh | Open |
| 27 Sep 2019 | Others | ₹3 Cr | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Op Pharma Distributor Private Limited
Op Pharma Distributor Private Limited has a workforce of 5 employees as of Mar 28, 2024.
Employee Count & EPFO Data of Op Pharma Distributor Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Op Pharma Distributor Private Limited
GSTIN & GST Filing Data of Op Pharma Distributor Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Op Pharma Distributor Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Op Pharma Distributor Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Op Pharma Distributor Private Limited
MSME Payment Delays by Op Pharma Distributor Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Op Pharma Distributor Private Limited
Subsidiaries & Group Companies of Op Pharma Distributor Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Op Pharma Distributor Private Limited with ownership details.
MCA Filings & Documents of Op Pharma Distributor Private Limited
MCA Filings & Documents of Op Pharma Distributor Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Op Pharma Distributor Private Limited
Frequently Asked Questions about Op Pharma Distributor Private Limited
Op Pharma Distributor Private Limited is an active private limited company in the pharma sector based in Ghaziabad, Uttar Pradesh, India. It was incorporated on 28 November 2018 (8+ years old) and is registered under CIN U51909UP2018PTC110696. The company has 5 employees.
Op Pharma Distributor Private Limited reported revenue of ₹19.82 Cr for FY 2023 (down 35.00% YoY).
The current directors of Op Pharma Distributor Private Limited are:
The primary industry of Op Pharma Distributor Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Op Pharma Distributor Private Limited can be reached at the registered office: 462 Sf Sk Shakti Khand Iii Indirapuram, Ghaziabad, Uttar Pradesh, India – 201010, or through the website oppharma.in.
The authorised capital is ₹10 Lakh, and the paid-up capital is ₹4.69 Lakh.